Top Clinical Trials companies in Norway by EBITDA Margin
This ranking features the top 4 Clinical Trials companies in Norway ranked by EBITDA Margin, averaging a EBITDA Margin of -13,637.50%, for February 07, 2025.
Norway
Clinical Trials
EBITDA Margin
Frequently Asked Questions
-
Which Clinical Trials company in Norway has the highest EBITDA Margin ?
The Clinical Trials company in Norway with the highest EBITDA Margin is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at -2.21%.
-
Which Clinical Trials company in Norway has the lowest EBITDA Margin ?
The Clinical Trials company in Norway with the lowest EBITDA Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -53,559.32%.
-
What are the top 10 Clinical Trials companies in Norway by EBITDA Margin ?
The top 10 Clinical Trials companies in Norway by EBITDA Margin are Gentian Diagnostics ASA, Lifecare AS, PCI Biotech Holding ASA and BerGenBio ASA.
-
What are the bottom 10 Clinical Trials companies in Norway by EBITDA Margin ?
The bottom 10 Clinical Trials companies in Norway by EBITDA Margin are BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS and Gentian Diagnostics ASA.
